987 related articles for article (PubMed ID: 20885410)
1. Microtubule-binding agents: a dynamic field of cancer therapeutics.
Dumontet C; Jordan MA
Nat Rev Drug Discov; 2010 Oct; 9(10):790-803. PubMed ID: 20885410
[TBL] [Abstract][Full Text] [Related]
2. [Antitubulin agents].
Dumontet C
Bull Cancer; 2011 Nov; 98(11):1275-85. PubMed ID: 22023745
[TBL] [Abstract][Full Text] [Related]
3. Microtubules: a dynamic target in cancer therapy.
Pasquier E; Kavallaris M
IUBMB Life; 2008 Mar; 60(3):165-70. PubMed ID: 18380008
[TBL] [Abstract][Full Text] [Related]
4. Microtubules and Cell Division: Potential Pharmacological Targets in Cancer Therapy.
Sebastian J; Rathinasamy K
Curr Drug Targets; 2023; 24(11):889-918. PubMed ID: 37519203
[TBL] [Abstract][Full Text] [Related]
5. Microtubule-targeting anticancer agents from marine natural substance.
Liu Z; Xu P; Wu T; Zeng W
Anticancer Agents Med Chem; 2014 Mar; 14(3):409-17. PubMed ID: 24533652
[TBL] [Abstract][Full Text] [Related]
6. Microtubules and resistance to tubulin-binding agents.
Kavallaris M
Nat Rev Cancer; 2010 Mar; 10(3):194-204. PubMed ID: 20147901
[TBL] [Abstract][Full Text] [Related]
7. Drug target interaction of tubulin-binding drugs in cancer therapy.
Sengupta S; Thomas SA
Expert Rev Anticancer Ther; 2006 Oct; 6(10):1433-47. PubMed ID: 17069528
[TBL] [Abstract][Full Text] [Related]
8. Microtubule Targeting Agents as Cancer Chemotherapeutics: An Overview of Molecular Hybrids as Stabilizing and Destabilizing Agents.
Tangutur AD; Kumar D; Krishna KV; Kantevari S
Curr Top Med Chem; 2017; 17(22):2523-2537. PubMed ID: 28056738
[TBL] [Abstract][Full Text] [Related]
9. Securinine induces mitotic block in cancer cells by binding to tubulin and inhibiting microtubule assembly: A possible mechanistic basis for its anticancer activity.
Ashraf SM; Mahanty S; Rathinasamy K
Life Sci; 2021 Dec; 287():120105. PubMed ID: 34756929
[TBL] [Abstract][Full Text] [Related]
10. Tubulin and microtubules as targets for anticancer drugs.
Hadfield JA; Ducki S; Hirst N; McGown AT
Prog Cell Cycle Res; 2003; 5():309-25. PubMed ID: 14593726
[TBL] [Abstract][Full Text] [Related]
11. Development of novel derivatives of stilbene and macrocyclic compounds as potent of anti-microtubule factors.
Borys F; Tobiasz P; Poterała M; Krawczyk H
Biomed Pharmacother; 2021 Jan; 133():110973. PubMed ID: 33378993
[TBL] [Abstract][Full Text] [Related]
12. Update on tubulin-binding agents.
Attard G; Greystoke A; Kaye S; De Bono J
Pathol Biol (Paris); 2006 Mar; 54(2):72-84. PubMed ID: 16545633
[TBL] [Abstract][Full Text] [Related]
13. Tubulin folding pathways: implication in the regulation of microtubule dynamics.
Beghin A; Galmarini CM; Dumontet C
Curr Cancer Drug Targets; 2007 Dec; 7(8):697-703. PubMed ID: 18220530
[TBL] [Abstract][Full Text] [Related]
14. Marine Derived Anticancer Drugs Targeting Microtubule.
De O; Chatterji BP
Recent Pat Anticancer Drug Discov; 2017; 12(2):102-127. PubMed ID: 28067173
[TBL] [Abstract][Full Text] [Related]
15. Microtubule alterations and resistance to tubulin-binding agents (review).
Drukman S; Kavallaris M
Int J Oncol; 2002 Sep; 21(3):621-8. PubMed ID: 12168109
[TBL] [Abstract][Full Text] [Related]
16. Taccalonolide binding to tubulin imparts microtubule stability and potent in vivo activity.
Risinger AL; Li J; Bennett MJ; Rohena CC; Peng J; Schriemer DC; Mooberry SL
Cancer Res; 2013 Nov; 73(22):6780-92. PubMed ID: 24048820
[TBL] [Abstract][Full Text] [Related]
17. Microtubule-associated proteins as targets in cancer chemotherapy.
Bhat KM; Setaluri V
Clin Cancer Res; 2007 May; 13(10):2849-54. PubMed ID: 17504982
[TBL] [Abstract][Full Text] [Related]
18. Stabilizing versus destabilizing the microtubules: a double-edge sword for an effective cancer treatment option?
Fanale D; Bronte G; Passiglia F; Calò V; Castiglia M; Di Piazza F; Barraco N; Cangemi A; Catarella MT; Insalaco L; Listì A; Maragliano R; Massihnia D; Perez A; Toia F; Cicero G; Bazan V
Anal Cell Pathol (Amst); 2015; 2015():690916. PubMed ID: 26484003
[TBL] [Abstract][Full Text] [Related]
19. Tubulins as therapeutic targets in cancer: from bench to bedside.
Katsetos CD; Dráber P
Curr Pharm Des; 2012; 18(19):2778-92. PubMed ID: 22390762
[TBL] [Abstract][Full Text] [Related]
20. Tubulin/microtubules: still a promising target for new chemotherapeutic agents.
Giannakakou P; Sackett D; Fojo T
J Natl Cancer Inst; 2000 Feb; 92(3):182-3. PubMed ID: 10655426
[No Abstract] [Full Text] [Related]
[Next] [New Search]
